Analysis: Teva Pharmaceuticals is bogged down by legal issues, fails to kick-start growth | Ctech
Watch CNBC's full interview with Teva Pharmaceuticals CEO Kare Schultz - YouTube
Israel's Teva Pharm in talks to co-produce COVID-19 vaccines, CEO says
Teva CEO Kare Schultz on coronavirus treatment and a possible second wave
Teva CEO Schultz took a big pay cut last year—but he bagged a contract extension, too | Fierce Pharma
Teva CEO Kåre Schultz discusses company's latest quarter and opioid settlement - YouTube
Teva CEO: Company Would Have Gone Bankrupt Without Layoffs - Business - Haaretz.com
Teva Pharmaceutical CEO on Bringing His Company Back from the Brink | Barron's
Kare Schultz | C-SPAN.org
After turbulent years, Teva CEO Schultz forecasts stability - Israel News - The Jerusalem Post
Teva Appoints Lundbeck's Schultz as CEO | Ctech
Teva poaches Lundbeck's Schultz as new CEO - PMLiVE
Kåre Schultz - Disability:IN
Teva Punished After Weak Outlook (NYSE:TEVA) | Seeking Alpha
Teva CEO Says Drugmaker Will Fight US Price-Fixing Charges (2)
Teva CEO Kare Schultz's pay fell in 2021 - Globes
Watch CNBC's full interview with Teva CEO Kåre Schultz
Teva's new CEO Schultz to take post Wednesday | The Times of Israel
Teva Appoints New Chief Executive After Months of Speculation - WSJ
Kåre Schultz is Named New President & CEO of Teva Pharmaceutical
Teva finally nabs a CEO, and it's Lundbeck helmsman—and Novo ex—Kåre Schultz | Fierce Pharma
Teva to Settle US Opioid Lawsuits for $4.35 Billion | The Jewish Press - JewishPress.com | David Israel | 28 Tammuz 5782 – July 27, 2022 | JewishPress.com
Nobody Thought It Would Come to This': Drug Maker Teva Faces a Crisis - The New York Times
Teva Names Kare Schultz as President and Chief Executive Officer - Pharmaceutical Processing World
Teva CEO Schultz: 'Proof Is In The Pudding' For US Biosimilars :: Generics Bulletin